Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06431269

Feasibility and Efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children With Congenital Heart Disease

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
270 (estimated)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
1 Year – 5 Years
Healthy volunteers
Not accepted

Summary

Feasibility and efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children aged 1 to 5 with Congenital Heart Disease

Detailed description

Congenital heart disease (CHD) is the leading cause of birth defects. Over 90% of children born with CHD reach adulthood. 50% of them will develop a neurodevelopmental disorder (NDD) that could affect life and long-term prognosis, including scholar and social integration and health related quality of life. In France, there is a lack of medical resources to screen NDD in this population and to refer patients for appropriate and early treatment. Investigators plan to propose a systematic early screening of NDD by an Advanced Practice Nurse (APN) during the usual cardiac follow-up. Children with CHD aged 1 to 5 will be included. If NDD is suspected, the patient will be referred to a neuropsychologist for NDD diagnosis confirmation and management planning. Patients with higher NDD risks (neonatal cardiac surgery) will benefit from a systematic neuropsychologist evaluation. This study will investigate the feasibility and performance of an APN screening in this NDD-high risk population.

Conditions

Interventions

TypeNameDescription
OTHERScreening for neurodevelopmental disorders by an advanced practice nurseScreening for neurodevelopmental disorders by an advanced practice nurse with Ages \& Stages Questionnaires (ASQ-3) and Haute Autorité de Santé (HAS) identification scale

Timeline

Start date
2024-05-31
Primary completion
2028-06-01
Completion
2028-06-01
First posted
2024-05-28
Last updated
2025-09-25

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06431269. Inclusion in this directory is not an endorsement.